About Praesidia Biotherapeutics

The Praesidia scientific team brings together seasoned drug discovery experts with deep expertise in chemistry and biology, united by a shared commitment to advancing best-in-class therapeutics for CNS disorders. 



With decades of experience across a broad range of programs, the Praesidia team is uniquely equipped to tackle complex challenges in drug discovery and development. Our specialized knowledge in medicinal chemistry and CNS biology underpins our innovative approach to brain-selective prodrugs—designed to maximize therapeutic efficacy while minimizing peripheral side effects.

Praesidia Leadership

Chhaya Shah

Chief Executive Officer

Legal Counsel

Julia Jones

Finance

Karthika Nair

Operations

Nick Camp, PhD

Chemist

Kevin Fales,  PhD

Chemist

Mary Mader, PhD

Chemist

Bryan Norman, PhD

Chemist

David McKinzie, PhD

Biologist

Dod Michael, PhD

Biologist

Board of Directors

Pasha Sarraf, MD, PhD

Executive Chair

Shawn Titcomb

Director

Martin Lehr

Independent Director

Join Us. Make a Difference.

Become a part of our team to build Praesidia with shared values and unifying organizational objectives.

Having successfully built organizations from scratch, Praesidia Management strongly believes that success of a business, be its science or balance sheet or social impact, depends on the organizational culture of the company.



Praesidia is a team where every individual takes ownership in every aspect of the organization and is not driven merely by their job responsibility on paper.



Building blocks of the Praesidia team are experts who are not only passionate about what they do but also has the conviction that their passion would translate in to meaningful impact under the Praesidia umbrella.



If you are such an individual who believes that the organizational goal is always larger than any personal glory, then do look out for our important position requirements posted here in the future.

Email Us

Get in Touch

Meeting the best possible standard of care requires the cooperation of many. We welcome conversations with potential new partners, investors, and those who may contribute to our efforts.

Contact Us